The American Academy of Dermatology and Galderma announce New, Innovative Research Fellowship Press release
Galderma and NovaBay Enroll First Patients in Phase 2b Clinical Study of NVC-422 for Impetigo Press release
Galderma announces Completion of Phase 3 Trials of Investigational Drug targeting Facial Erythema of Rosacea Press release
Galderma receives FDA Approval for new convenient Pump Dispenser of Differin Gel, 0.3% for treatment of Acne Vulgaris Press release
Galderma Announces Availability of New Metrogel 1% Pump Dispenser for the Treatment of Papulopustular Rosacea Press release
